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CBPPorcine reproductive and respiratory syndrome (PRRS) is an emerged disease of swine characterized by
negligible response of type I IFNs and viral persistence. We show that the PRRSV non-structural protein 1
(Nsp1) is the viral component responsible for modulation of IFN response. Nsp1 blocked dsRNA-induced
IRF3 and IFN promoter activities. Nsp1 did not block phosphorylation and nuclear translocation of IRF3 but
inhibited IRF3 association with CREB-binding protein (CBP) in the nucleus. While IRF3 was stable, CBP was
degraded, and CBP degradation was proteasome-dependent, suggesting that CBP degradation is not due to
the protease activity of Nsp1 but an intermediary is involved. Our data suggest that the Nsp1-mediated CBP
degradation inhibits the recruitment of CBP for enhanceosome assembly, leading to the block of IFN
response. CBP degradation is a novel strategy for viral evasion from the host response, and Nsp1 may form a
new class of viral antagonists for IFN modulation., 2001 South Lincoln Avenue,
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Porcine reproductive and respiratory syndrome (PRRS) is an
emerged and re-emerging disease of swine. PRRS was ﬁrst recognized
in 1987 in the U.S. and in Germany in 1990 independently (Keffaber
1989; Benﬁeld et al., 1992). PRRS quickly spread globally to most pig-
producing countries and has become one of the most economically
important diseases to thepork industryworldwide. Since its emergence,
PRRS virus (PRRSV) has continued to evolve. A new type of PRRSV has
recently been identiﬁed in the U.S. (Ropp et al., 2004; Fang et al., 2007),
and in2006, ahighly virulentPRRSVappeared inChina (Tianet al., 2007;
Tong et al., 2007; Zhou et al., 2008) which has spread to neighboring
countries (Normile 2007; Feng et al., 2008; Kukushkin et al., 2008).
PRRSV infection in pigs may last for a prolonged period of up to
180 days (Wills et al., 2003; Christopher-Hennings et al., 1995; Albina
et al., 1994; Lamontagne et al., 2003). Studies show that PRRSV is highly
susceptible to the action of type I IFNs in cells (Albina et al., 1998;
Overend et al., 2007), suggesting that the virus may function to inhibit
IFN-α response as this cytokine is not detectable in the lungs of pigswhere PRRSV actively replicates by infecting alveolar macrophages
(Buddaert et al., 1998; van Reeth et al., 1999; Luo et al., 2008; Lee et al.,
2004; Miller et al., 2004). The molecular basis for IFN suppression by
PRRSV has not been studied but the involvement of NF-κB has been
excluded since it is up-regulated by the virus (Lee andKleiboeker, 2005).
Impairment of IFN-α production by PRRSV would affect the develop-
ment of an effective T helper type 1 (Th1) response and lead to aweakly
induced cellular response and consequently viral persistence in infected
pigs, which would be of signiﬁcant beneﬁt to the virus. Different PRRSV
isolates seem to have different abilities to induce or inhibit IFN-α (Lee
et al., 2004), and this differencemaybeattributed to thegenetic diversity
of PRRSV. Although several lines of evidence suggest that PRRSV
possesses immunosuppressive properties (Done and Paton, 1995;
Drew, 2000; Jung et al., 2009), the mechanism for virulence and
persistenceof PRRSV is yet unclear. It is postulated that at least oneof the
mechanisms may be related to the modulation of type I IFN production
by PRRSV.
Viral infections lead to activation of several cellular transcription
factors including interferon regulatory factor 3 (IRF3), nuclear factor-κB
(NF-κB) and activating transcription factor 2 (ATF2), to subsequently
trigger the synthesis and secretion of IFN-β (Bowie and Unterholzner,
2008; Sadler andWilliams, 2008; Takeuchi andAkira, 2008; Randall and
Goodbourn, 2008; De Clercq, 2006; Pichlmair and Sousa, 2007). Among
those factors involved in type I IFN production, IRF3 plays a major
role. IRF3 is constitutively expressed in most cell types and present
in the cytoplasm in its inactive form. When stimulated, IRF3 becomes
316 O. Kim et al. / Virology 402 (2010) 315–326phosphorylated and undergoes conformational change, leading to
dimerization and unveiling of the nuclear localization signal (NLS),
and translocates to the nucleus where it forms a complex with the
transcription co-activator CREB (cAMP responsive element binding)-
binding protein (CBP)/p300 (Lin et al., 1998; Dragan et al., 2007; Panne
et al., 2007). The IRF3-CBP/p300 complex in the nucleus then binds to
target sequences including the positive regulatory domain (PRD) I–III
regions of the IFN-β promoter and forms the assembly of basal
transcriptionmachinery andRNApolymerase II for IFNgene expression.
Therefore, the transcriptional activity of IRF3 is entirely dependent on its
association with CBP/p300 co-activators. Once IFN is expressed, it is
extracellularly secreted and binds to IFN receptors on the cell
membrane, which subsequently triggers the IFN signaling cascade
through Janus kinase (JAK)-mediated signal transducers and activators
of the transcription (STAT) pathway. This series of IFN pathways
regulate the expression of more than a hundred IFN-stimulated genes
(ISGs) that are mostly related to innate immunity and thus specify the
antiviral state of the host. In turn,many viruses have evolved to prevent
the production of type I IFN for their survival in the host, and ample
examples are available (for reviews, see Koyama et al., 2008; Randall
and Goodbourn, 2008; Pichlmair and Sousa, 2007).
PRRSV is a porcine arterivirus belonging to the family Arteriviridae
in the order Nidovirales. PRRSVs in North America and Europe share
only 55–80% of sequence identity in the different viral genes and thus
form two distinct genotypes (Meng et al., 1995). The viral genome is a
positive-sense RNA of approximately 15 kb in size and contains 9
ORFs: ORF1a and ORF1b code for two large non-structural poly-
proteins (PP1a and PP1ab), and ORF2a, ORF2b, and ORF3 through
ORF7 code for structural proteins E (small envelope), GP2 (glycopro-
tein 2), GP3, GP4, GP5, M (membrane), and N (nucleocapsid),
respectively (Wootton et al., 2000; Meulenberg et al., 1993). The
ORF1a product (PP1a) is 2503 amino acids long, while ORF1b is
expressed through ribosomal frameshifting to generate an ORF1ab
fusion protein (PP1ab) of 3960 amino acids (den Boon et al., 1991;
Wootton et al., 2000). For PRRSV, PP1a and PP1ab are co-translation-
ally processed to 13 proteolytic cleavage products; Nsp1α, Nsp1β, and
Nsp2 through Nsp12 in order from the N-terminus (Wassenaar et al.,
1997; Snijder et al., 1992; Snijder et al., 1994; Snijder et al., 1995).
Therefore, Nsp1 is the ﬁrst viral protein synthesized in cells upon
infection. Nsp1 is a 382-amino acid protein and contains two papain-
like cysteine proteinase (PCP) domains, designated PCPα and PCPβ .
The protease activity of PCPα has been predicted to be responsible for
generation of Nsp1α, and the PCPβ activity generates Nsp1β by
cleaving it from Nsp2 during the PP1a/PP1ab synthesis (den Boon
et al., 1995). After cleavage of Nsp1, no trans-cleavage protease
activity is observed for Nsp1 and therefore its enzymatic activity
seems to be no longer functional in equine arteritis virus (EAV). PCPα
activity seems to be required for subgenomic mRNA synthesis but is
not involved in viral genome replication (Kroese et al., 2008). A zinc
ﬁnger motif is found in the N-terminal region of Nsp1α, and this motif
along with PCPα activity is required for transactivation of subgenomic
RNA synthesis (Tijms and Snijder, 2003; Tijms et al., 2001; Tijms et al.,
2007). In EAV, Nsp1α is not cleaved from Nsp1β and has been
observed to localize in the nucleus (Tijms et al., 2002). Similarly,Fig. 1. Suppression of type I IFN production by PRRSV. (A) Quantitative RT-PCR for IFN-αmR
PRRSV or Sendai virus at an MOI of 5 and at 24 h post-infection, transfected with 1 μg of poly(
and GAPDH reverse primers. Messenger RNA levels of indicated genes were normalized to t
were averaged. This data represents two separate experiments in duplicate. (B) IFN bioassay
48 h and supernatants were collected for IFN bioassay. Sendai virus was used as an IFN stimu
distance prior to assay. Dulac porcine kidney cells were grown in 96well plates and incubated
and at 16 h post-infection, ﬁxed with 4% paraformaldehyde for ﬂuorescence microscopy. (C
were grown to 80% conﬂuency in 12-well plates and infected with PRRSV for 24 h. Virus-in
luciferase reporter or IFN-β-luciferase reporter construct along with the Renilla internal cont
(I:C) for 15 h and the luciferase activities were measured using the Dual Luciferase assay sys
activity of poly(I:C)-treated cells divided by that of control. Data representing the relative ﬁ
were conducted twice in triplicates.PRRSV Nsp1 protein has also been observed to localize in the nucleus
in addition to the cytoplasmic distribution (unpublished observation).
Since PRRSV is a cytoplasmic RNA virus that does not require the
nuclear function of the host cell for replication and because Nsp1 is
observed in the nucleus, it has prompted us to examine the role of
Nsp1 for IFN modulation. In the present study, we investigated the
basis for IFN regulation by PRRSV and determined Nsp1 as the
responsible protein for IFN down-regulation. PRRSV Nsp1 induced
CBP degradation and interrupted the IRF3 binding to CBP, which in
turn resulted in IFN down-regulation. Our study shows a novel
function of the Nsp1 protein during PRRSV infection and provides new
insight into the immunemodulation and evasion strategy of this virus.
Results
Suppression of type I IFN production by PRRSV
To conﬁrm the suppression of type I IFN induction by PRRSV,
quantitative RT-PCR was performed for IFN-αmRNA. MARC-145 cells
were ﬁrst infected with PRRSV and then stimulated with poly(I:C),
followed by total cellular RNA extraction for real-time RT-PCR.
While IFN-α is effectively induced in response to poly(I:C) (13),
infection with PRRSV suppressed the poly(I:C)-induced IFN-α mRNA
production in MARC-145 cells (Fig. 1A). In parallel with the
quantitative measurements for IFN-α mRNA, reduced production of
IFN by PRRSV was conﬁrmed by IFN bioassays using VSV-GFP. VSV is
exceptionally sensitive to IFNs and thus is commonly used in assays
for IFN-mediated antiviral activities, while Sendai virus is used as an
effective inducer of type I IFN. Dulac PK cells were incubated ﬁrst with
cell culture supernatants, collected from PRRSV and Sendai virus-
infected PAMs then UV-irradiated. The Dulac PK cells were then
infected with VSV-GFP and the VSV infectivity was determined by
monitoring the levels of GFP expression. VSV-GFP grew normally in
PRRSV-uninfected and Sendai virus-uninfected cells and produced
ﬂuorescence at a low dilution of the supernatant (Fig. 1B, upper
panels). Sendai virus infection inhibited VSV replication effectively,
and no visible GFP expression was identiﬁed up to 1:8 dilution of the
culture supernatant (middle panels), showing efﬁcient production of
IFN in alveolar macrophages. In contrast, infection of cells with PRRSV
did not inhibit VSV replication and GFP expression was evident even
at low dilutions (lower panels).
IFN-α/β production is activated when IRF3, ATF2 and NF-κB bind
to PRD (positive regulatory domain) I/III, PRD II, and PRD IV of the
IFN-β promoter, respectively. Among these transcription factors, IRF3
plays a major role in IFN-β gene expression. PRRSV infection activates
the NF-κB signaling pathway through IκB degradation and the up-
regulation of MMP (matrix metalloproteinase)-2 and MMP-9 expres-
sions (Lee and Kleiboeker, 2005), suggesting that PRRSV-induced IFN
down-regulation may likely involve the IRF3 pathway rather than the
NF-κB pathway. To examine the role of IRF3 during PRRSV infection, a
luciferase assay was conducted using the 4xIRF3-Luc reporter construct
(Ehrhardt et al., 2004). This construct contains 4 copies of the IRF3
responsive PRDI/III region of the IFN-β enhanceosome coupled with
luciferase, and thus IFN-βexpression couldbedeterminedusing4xIRF3-NA in PRRSV-infected cells. MARC-145 cells grown in 6-well plates were infected with
I:C) for 15 h. Total cellular RNAwas extracted and cDNAwas prepared using both IFN-α
hat of GAPDH mRNA. Normalized values obtained from each infection and transfection
for PRRSV using VSV-GFP. Porcine alveolar macrophages were infected with PRRSV for
lator. The supernatants were UV-irradiated for 30 min under a 75 WUV lamp at a 33 cm
with 2-fold diluted samples for 24 h. Cells were then infected with VSV-GFP at 0.1 MOI,
) Down-regulation of 4xIRF3 and IFN-β promoter activities by PRRSV. MARC-145 cells
fected cells were transfected with a total of 0.5 μg of TATA-luciferase reporter, 4xIRF3-
rol at a ratio of 1:0.1. At 24 h post-transfection, cells were stimulated with 0.5 μg of poly
tem (Promega). Results are presented as the fold induction that is the relative luciferase
reﬂy luciferase activity were normalized to Renilla luciferase activity. Luciferase assays
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PRRSV. Upon poly(I:C) stimulation, the luciferase activity was signiﬁ-
cantly increased for both 4xIRF3-Luc and IFN-β-Luc. In PRRSV-infected
cells however, the luciferase activity decreased for both IRF3-Luc and
IFN-β-Luc (Fig. 1C), showing suppressions of both IRF3 activation and
IFN-β expression by PRRSV.
Suppression of IFN production by Nsp1
Theﬁrst viral protein synthesized in cells after PRRSV infection isNsp1
which is the N-terminal cleavage product generated from PP1a/PP1abFig. 2. Suppression of type I IFN production by Nsp1. (A) HeLa cells grown in 12-well plates
4xIRF3-luciferase reporter (left panel) or IFN-β-luciferase reporter gene (right panel) and
transfected with 0.5 μg of poly(I:C) for 16 h, and luciferase activities were determined using
Western blot using anti-Flag antibody to examine differential levels of Nsp1 expression (imm
luciferase activity of poly(I:C)-treated cells divided by that of control. Data representing
the internal control. Luciferase assays were conducted twice in triplicates. (B) IFN bioassay us
6-well plates were transfected with pCMV-Flag-Nsp1 for 24 h and stimulated with poly(I:C)
bioassay. MARC-145 cells were grown in 96-well plates and incubated with each dilution of
VSV replication was measured by monitoring ﬂuorescence. Top panels, VSV-GFP replicat
supernatants collected from poly(I:C)-stimulated cells; bottom panels, supernatants collectpolyproteins by cis-proteolytic cleavage for self-release from Nsp2. The
Nsp1 protein of EAV has been reported to localize in the nucleus and the
cytoplasm (Tijms et al., 2002). Similarly, we observed that the PRRSV
Nsp1 protein also localized in the nucleus in virus-infected cells aswell as
in Nsp1 gene-transfected cells (unpublished data), suggesting that Nsp1
may have a dual function in the nucleus and the cytoplasmic
compartment. Since PRRSV was shown to possess the down-regulating
activity for IFN response (Fig. 1), we hypothesized that this activity may
be associated with Nsp1 and examined its function using the 4xIRF3-Luc
and IFN-β-Luc reporter systems. The poly(I:C) stimulation increased both
IRF3 and IFN-β promoter activities in HeLa cells as expected, while theat 80% conﬂuency were co-transfected with indicated amounts of pCMV-Flag-Nsp1 and
the Renilla internal control at a ratio of 1:1:0.1. At 24 h post-transfection, cells were
the Dual Luciferase assay system (Promega). In parallel, cell lysates were analyzed by
unoblot on the left panel). Results are presented as the fold induction that is the relative
the relative ﬁreﬂy luciferase activity were normalized to Renilla luciferase activity as
ing VSV-GFP for culture supernatants collected fromNsp1-expressing cells. HeLa cells in
for 6 h. Cell culture supernatants were collected and diluted serially by 2-folds for VSV
the supernatant for 24 h, followed by infection with VSV-GFP at an MOI of 0.1 for 16 h.
ion in cells treated with supernatants collected from untreated cells; middle panels,
ed from pCMV-Flag-Nsp1 transfected and poly(I:C)-stimulated cells.
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dose-dependent manner (Fig. 2A). This result provides evidence that the
PRRSV Nsp1 protein may function to inhibit the IRF3 activity and IFN-β
promoter activity.
To further demonstrate that IFN suppressionwasmediated byNsp1,
a VSV-GFP bioassay was conducted using the culture supernatant
collected from the pCMV-Flag-Nsp1 transfected cells (Fig. 2B). While
GFP expression was absent in cells incubated with the supernatant
collected from poly(I:C)-stimulated cells (middle panels), VSV replica-
tion was evident in cells treated with a low dilution of supernatant
collected from pCMV-Flag-Nsp1 transfected cells (bottom panels), and
the GFP expression was comparable to those in cells without poly(I:C)
stimulation (upper panels). The bioassay results show the inhibition of
VSV replication by Nsp1 and demonstrate that Nsp1 is a responsible
factor for IFN down-regulation by PRRSV.Nsp1 does not prevent IRF3 phosphorylation and nuclear translocation
IRF3 is ubiquitously expressed in the cytoplasm and activated in
response to extracellular stimuli including viral infection. When
stimulated, IRF3 is phosphorylated by an upstream kinase and
homodimerized in the cytoplasm for translocation to the nucleus.
Some viruses have evolved to interfere with the IRF3 pathway and
inhibit the induction of IFN-α/β. Common mechanisms used by these
viruses include degradation of IRF3, inhibition of IRF3 phosphorylation,
inhibition of IRF3 nuclear translocation, or inhibition of transcription
complex assembly. We ﬁrst examined if IRF3 phosphorylation was
blocked by PRRSV. The poly(I:C) stimulation triggered the phosphor-
ylation of IRF3 in both MARC-145 cells (Fig. 3A, top panel, lane 2) and
HeLa cells (Fig. 3B, top panel, lane 2) as expected. Infection with PRRSV
followed by stimulation with poly(I:C) did not alter IRF3 phosphory-
lation in MARC-145 cells (Fig. 3A, top panel, lane 3), although both
Nsp1α and Nsp1βwere readily detectable by speciﬁc antibody (Fig. 3A,
lane 3). Similarly, in pCMV-Flag-Nsp1 transfected HeLa cells, IRF3Fig. 3. Phosphorylation of IRF3 in the presence of Nsp1. (A) Phosphorylation of IRF3 in
PRRSV-infected cells. MARC-145 cells were infected with PRRSV for 24 h and induced
by poly(I:C) for 6 h. Cells were lysed and subjected to Western blot analysis using
phospho-IRF3 (Ser396) antibody (top panel), IRF3 antibody (second panel), rabbit anti-
Nsp1 serum (third panel), and β-actin antibody (bottom panel). (B) Phosphorylation of
IRF3 in Nsp1 gene-transfected cells. HeLa cells were transfected with Nsp1 for 24 h and
stimulated by poly(I:C) for 6 h. Cells were lysed and subjected to Western blot analysis
using phospho-IRF3 (Ser396) (top panel), IRF3 antibody (middle panel), and Flag
antibody (bottom panel).phosphorylation still occurred (Fig. 3B, top panel, lane 3), suggesting
that the suppression of IRF3 activity by PRRSV and Nsp1 takes place
downstream of the IRF3 phosphorylation.
To further determine the basis of modulation of IRF3 activity by
Nsp1, nuclear translocation of IRF3 was examined by immunoﬂuo-
rescence. PRRSV-infected MARC-145 cells were stimulated with poly
(I:C), and the endogenous IRF3 was stained with speciﬁc antibody
(Fig. 4A). While IRF3 was mainly distributed in the cytoplasm with
some nuclear diffusion in the absence of stimulation (panels A, C),
IRF3 was predominantly translocated to the nucleus after poly(I:C)
stimulation (panels D, F). PRRSV-infected cells were identiﬁed by the
staining of N protein (panel G), and PRRSV infection followed by poly
(I:C) stimulation did not block the nuclear translocation of IRF3
(panels H, J), supporting the efﬁcient phosphorylation of IRF3 even in
the presence of Nsp1. These results suggest that Nsp1-mediated
suppression of both IRF3 activation and IFN production occurs further
downstream of the IRF3 nuclear translocation. The nuclear localiza-
tion of IRF3 was also examined in pCMV-Flag-Nsp1 transfected cells
(Fig. 4B). As with MARC-145 cells, HeLa cells showed the efﬁcient
translocation of IRF3 to the nucleus upon poly(I:C) stimulation
(panels A, C), and the nuclear translocation of IRF3 was not blocked
by the Nsp1 protein (panels H, J), as the Nsp1 expression in the same
cell was veriﬁed by anti-Flag antibody (panel G).
The nuclear translocation of IRF3 in the presence of Nsp1 was
conﬁrmed by cell fractionation of pCMV-Flag-Nsp1 transfected cells
(Fig. 5). With poly(I:C) stimulation, IRF3 was largely found in the
nuclear fraction, and the IRF3 nuclear translocation was unaffected by
Nsp1 expression (lanes 4, 5, 6). HSP90 and PARP, the cytosolic and
nuclear protein markers respectively, remained in the cytoplasm
(lanes 1, 2, 3) and the nucleus (lanes 4, 5, 6), respectively, eliminating
the possible cross-contamination of both fractions. The cell fraction-
ation data conﬁrmed active translocation of IRF3 in the nucleus
despite the presence of Nsp1 and showed that the modulation of IRF3
activation occurs in the nucleus rather than in the cytoplasm.
Inhibition of IRF3 association with CBP by Nsp1 and CBP degradation
Following phosphorylation and dimerization, IRF3 translocates to
the nucleus and recruits CBP and/or p300 for full activation. This
complex then binds to PRD I/III of the IFN-β promoter for
transcription activation and IFN production. Since Nsp1 did not alter
IRF3 phosphorylation and nuclear translocation, Nsp1 was hypothe-
sized to play a role during assembly of IRF3 with CBP/p300 for
transcriptional complex formation in the nucleus. To examine the role
of Nsp1 in IRF3 association with CBP, co-immunoprecipitation was
conducted for PRRSV-infected cells (Fig. 6A) and pCMV-Flag-Nsp1
transfected cells (Fig. 6B). MARC-145 cells were infected with PRRSV
for 24 h and stimulated with poly(I:C). Cell lysates were then
prepared and subjected to immunoprecipitation using an IRF3-
speciﬁc antibody. The immune complexes were resolved by SDS-
PAGE and analyzed byWestern blot using the CBP antibody.While the
association of IRF3 with CBP was evident in cells stimulated with poly
(I:C) (Fig. 6A, top panel, lane 2), this association decreased in virus-
infected poly(I:C)-stimulated cells (top panel, lane 3). In these cells,
both Nsp1α and Nsp1β subunits were readily detectable as 20 kD and
28 kD proteins (panel 4, arrows), respectively, and CBP association
with IRF3 was signiﬁcantly reduced. In HeLa cells transfected with
pCMV-Flag-Nsp1, the amount of CBP associated with IRF3 also
decreased signiﬁcantly by Nsp1 protein (Fig. 6B, top panel, lane 3),
whereas detectable levels of IRF3 remained unchanged (second panel,
lane 3). In unstimulated cells, CBP was detectable in negligible
amounts (top panel, lane 1), most likely because IRF3 would not be
activatedwithout poly(I:C) stimulation, thus resulting in the failure of
CBP recruitment by IRF3.
The decrease in the amount of CBP itself was observed in the
presence of Nsp1 and poly(I:C) stimulation (Fig. 6B, second panel from
Fig. 4. Nuclear translocation of IRF3 in the presence of Nsp1. (A) Nuclear translocation of IRF3 in PRRSV-infected cells. MARC-145 cells grown to 40% conﬂuency in cover slips were
infected with PRRSV for 24 h and stimulated with poly(I:C) for 6 h. Cells were washed with PBS and ﬁxed with 4% paraformaldehyde. Cells were then incubated with anti-IRF3
antibody and anti-PRRSV N antibody (SDOW17), followed by incubation with Alexa Fluor 488-conjugated (green) and 594-conjugated (red) secondary antibodies, respectively,
along with DAPI for nuclear staining (blue). Upper panels, IRF3 localization in the cytoplasm without poly(I:C) stimulation; middle panels, IRF3 localization in the nucleus upon poly
(I:C) stimulation; bottom panels, IRF3 localization in the nucleus in PRRSV-infected and poly(I:C) stimulated cells. Arrows indicate PRRSV-infected cells. (B) Nuclear translocation of
IRF3 in Nsp1 gene-transfected cells. HeLa cells grown to 50% conﬂuency were transfected with Nsp1 gene for 24 h and stimulated with poly(I:C) for 6 h. Cells were washed with PBS,
ﬁxed with 4% paraformaldehyde, and incubated with anti-IRF3 antibody and anti-Flag antibody to detect Nsp1, followed by incubation with Alexa Fluor 488-conjugated (green) and
594-conjugated secondary antibodies (red), respectively, along with DAPI for nucleus staining (blue). Upper panels, IRF3 localization in the cytoplasmwithout poly(I:C) stimulation;
middle panels, nuclear localization of IRF3 upon poly(I:C) stimulation; bottom panels, nuclear localization of IRF3 in the presence of Nsp1 and poly(I:C) stimulation. Arrows indicate
Nsp1-expressing cells.
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presence of Nsp1. The reduction of CBP would be expected if IRF3 was
unstable in the presence of Nsp1. However, IRF3 was found to remain
stable in the presence of Nsp1 (Figs. 3–5). In contrast, the amount of
CBP decreased dramatically in the presence of Nsp1 after treatment
with cycloheximide (CHX) (Fig. 6C). CBP was almost undetectable by
2 h of CHX treatment and by 4 h, was abolished (Fig. 6C, top panel,
lanes 4 and 6). Nsp1 remained stable and at a constant level (middle
panel). These results indicate that CBP was degraded by Nsp1.Since PRRSV Nsp1 is a cysteine protease, CBP degradation was
assumed to occur through protease activity of Nsp1 such that Nsp1
may bind to CBP and degrade it as the substrate. To determine if Nsp1
bound to CBP, co-immunoprecipitation was conducted (Fig. 7). Cells
expressing Nsp1 were immunoprecipitated using anti-CBP antibody
and probed with anti-Flag antibody for detection of Nsp1 (panels 1).
Alternatively, Nsp1-expressing cells were co-immunoprecipitated
using anti-Nsp1 rabbit serum and probed with anti-CBP antibody
(panel 3). Despite the expression of both Nsp1α and Nsp1β in Nsp1
Fig. 5. Nuclear and cytoplasmic fractionation of cells expressing Nsp1 and identiﬁcation
of IRF3 in the nucleus. HeLa cells grown in 6-well plates were transfected with pCMV-
Flag-Nsp1 for 24 h and stimulated with poly(I:C) for 6 h. Cell fractionation was
performed for nuclear and cytosolic fractions, followed by Western blot analysis using
IRF3 antibody (panel 1, top panel), anti-Flag antibody for Nsp1 (panel 2), anti-HSP90 as
a cytosolic marker (panel 3), anti-PARP antibody as a nuclear protein marker (panel 4),
and β-actin antibody as a loading control (bottom panel).
321O. Kim et al. / Virology 402 (2010) 315–326gene-transfected cells (lane 3 in panels 4, 5, 6, and 7), no binding of
CBPwas identiﬁed (panels 1, 2, and 3), indicating that CBPwas not the
substrate of Nsp1. This ﬁnding is supported by reports that no trans-
protease activity was observed for Nsp1 once cleaved from Nsp2, and
Nsp1 is known to remain proteolytically inactive (Snijder et al., 1992,
1994, 1995).
Since CBP did not bind Nsp1, therefore was unlikely its substrate, a
possibility for CBP degradationwould beproteasome-mediated.MG132
is a potent inhibitor of proteasome-dependent degradation, and thus
the MG132 inhibitor assay was conducted (Fig. 8). While Nsp1-
mediated CBP degradation was evident in the absence of MG132
(Fig. 8, top panel, lane 2), as little as 1 μM of MG132 was sufﬁcient to
block CBP degradation (top panel, lane 3). This result conﬁrms that CBP
degradation was not due to Nsp1 protease activity but rather mediated
via the proteasome-dependent degradation pathway.
Discussion
Host cells are armed with the immune surveillance system to
protect themselves from viral infection, yet viruses have evolved to
escape this system for efﬁcient proliferation. Host cells produce
cytokines and chemokines in response to viral infection and among
such effectormolecules, type I IFNs are the principal antiviral cytokines
and are therefore effective targets for viruses to disarm host
surveillance (Koyama et al., 2008; Randall and Goodbourn, 2008;
Pichlmair and Sousa, 2007). Type I IFNs can be produced by virtually all
nucleated cells, in contrast to type II IFNwhich is exclusively produced
by T and natural killer (NK) cells. Many viruses including small RNA
viruses are known to express proteins that counteract the production
of type I IFN and such viral proteins are often multifunctional. Many
examples of different evasion strategies are available for different RNA
viruses, and IFN-antagonizing viral proteins include NS1 protein of
inﬂuenza virus (Min et al., 2007), V protein of paramyxoviruses
(Andrejeva et al., 2004), sigma 3 of reoviruses (Jacobs and Langland,
1998), NSP1 of rotavirus (Graff et al., 2007), P protein of rabies virus
(Brzozka et al., 2005), Npro of bovine viral diarrhea virus (BVDV) and
classical swine fever virus (CSFV) (Ruggli et al., 2005; La Rocca et al.,2005; Bauhofer et al., 2007), NS3-4A of hepatitis C virus (Luquin et al.,
2007), G1 protein of hantavirus, and Nsp1 and ORF6 proteins of severe
acute respiratory syndrome (SARS) coronavirus (Davaraj 2007;
Wathelet et al., 2007; Frieman et al., 2007) to name a few. These
proteins function to circumvent the IFN response by interfering with
host cell gene expression, blocking the IFN induction cascade, or
inhibiting the IFN signaling pathways. IRF3 is a key element for the
induction of the early antiviral response and is therefore an ideal target
by many viruses in modulating the IFN response.
In the present study, we have shown that PRRSV Nsp1 is an IFN-
antagonizing protein. Nsp1 appears to inhibit the 4xIRF3 and IFN-β
promoter activities and reduce IFN production. Since Nsp1 is a
cysteine protease, degradation of IRF3 was initially hypothesized as
the mechanism for IFN down-regulation by PRRSV. It is striking
however, that PRRSV Nsp1 appears to inhibit the recruitment of CBP
by IRF3 in the nucleus via CBP degradation. For full activation of IRF3,
the phosphorylated and dimerized form of IRF3 recruits co-activator
CBP/p300 in the nucleus, which directs the complex to bind to IRF3
responsive elements for transcription initiation (Yang et al., 2004;
Suhara et al., 2002). PRRSV Nsp1 does not appear to modify IRF3
phosphorylation or to block IRF3 nuclear translocation but rather
degrades CBP in the nucleus (Fig. 6). By degrading CBP, Nsp1 seems to
block the full activation of IRF3 and subsequently inhibit the assembly
of IFN enhanceosome.
During the preparation of this manuscript, Beura et al. (2010)
reported that, by using individual subunit constructs of Nsp1, Nsp1β
inhibited IRF3 nuclear translocation and down-regulated IFNβ
promoter activity. While it is unknown which subunit of Nsp1 is
responsible for CBP degradation in our study, Beura's report contra-
dicts our ﬁnding that Nsp1 did not block nuclear localization of IRF3
(Figs. 4, A and B, and 5). Recently, Sun et al. (2009) determined and
reported the three-dimensional structure of the Nsp1α subunit of
Nsp1 byX-ray crystallographic studies. In their study, the self-cleavage
site for Nsp1α was precisely located at Cys-Ala-Met180/Ala181-Asp-
Val to yield Nsp1α of 180 amino acids and Nsp1β of 202 amino acids.
This ﬁnding overturns the previous prediction of Nsp1α cleavage at
Q166/R/167 (den Boon et al., 1995), and shows that the naturally
cleaved Nsp1α subunit is 14-amino acids extended at the C-terminus
and thus Nsp1β is 14 amino acids shorter at its N-terminus when
compared to the previously predicted cleavage products. Furthermore,
this study identiﬁed the second zinc ﬁnger conﬁguration in the C-
terminal region of Nsp1α to hold a Zn++ ion, in addition to the ﬁrst zinc
ﬁnger present in the N-terminal region of Nsp1α, and the involvement
of Met180 in the second zinc ﬁnger conﬁguration, suggesting an
important biological function be associated with the newly identiﬁed
zinc ﬁnger structure. In support of this argument, Chen et al. (2010) has
also recently identiﬁed the precise cleavage site of Nsp1α to be Cys-Ala-
M180/Ala181-Thr-Val by peptide sequencing of two Nsp1 auto-
cleavage products of the North American type II PRRSV SD23938.
Therefore, it is conceivable that the recent report described by Beura et
al. (2010) in contrast to our ﬁnding may be attributed to the lack of the
zinc ﬁnger structure in Nsp1α and thus the N-terminal extension of the
Nsp1β portion in their constructs. In our current study, the full-length
Nsp1 gene for 382 amino acids was used throughout the experiments
and thus thenatural cleavage atMet180/Ala181wouldbeanticipated to
yield two authentic cleavage products of Nsp1α and Nsp1β. Further
studies will warrant the functional contribution of the newly identiﬁed
zinc ﬁnger structure in Nsp1 to its biological signiﬁcance.
The degradation of CBP is an uncommon yet a novel strategy of
viruses for IFN modulation. Thogoto virus, an orthomyxovirus, has
recently been studied for IFN suppression, and the Thogoto virus ML
protein, which is a homolog of the inﬂuenza virus NS1 protein, has been
found to interfere with IRF3 function. The ML protein however did not
block the nuclear transport of IRF3 but inhibited the association of IRF3
with CBP (Jennings et al., 2005). This result resembles our ﬁnding on the
function of Nsp1. CBP possesses histone acetyltransferase activity and
Fig. 6. Interruption of IRF3 and CBP association and CBP degradation by Nsp1. (A) Reduction of CBP binding to IRF3 in PRRSV-infected cells. MARC-145 cells were infected with PRRSV
for 24 h and stimulated with poly(I:C) for 6 h. Cell lysates were prepared and subjected to immunoprecipitation with anti-IRF3 antibody (top two panels) followed by Western blot
analysis using CBP antibody (top panel) or IRF3 antibody (second panel). Expression of CBP (panel 3), IRF3 (panel 4), and Nsp1 (panel 5) is shown. (B) Reduction of CBP binding to
IRF3 in pCMV-Flag-Nsp1 transfected cells. HeLa cells were transfected with Nsp1 gene for 24 h and stimulated with poly(I:C) for 6 h. Cells were lysed and subjected to co-
immunoprecipitation using anti-IRF3 antibody (top two panels), followed by Western blot analysis using CBP antibody (panel 1) and IRF3 antibody (panel 2). Expression of IRF3
(panel 3), Nsp1 (panel 4), and CBP (panel 5) is shown. (C) CBP degradation in the presence of Nsp1 during cycloheximide (CHX) treatment. HeLa cells were transfected with pCMV-
Flag-Nsp1 and treated with 100 μg/ml of CHX at 0, 2, 4 h, followed by Western blot analysis using anti-CBP antibody (top panel) and anti-Flag antibody for Nsp1 detection (middle
panel). The bottom panel of β-actin shows a loading control.
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The CBP/p300 co-activators function in concert with a variety of
transcription factors including c-Myb, p53, STATs, NF-κB, PIAS1, and the
IRF family (Barlev et al., 2001; Lin et al., 2000; Ma et al., 2005;
Oelgeschläger et al., 1996; Yin et al., 2005; Zhonget al., 2002). Therefore,
CBP acts as an important regulator for many cellular processes. The
question arises then whether Nsp1 interferes with general cellular
transcription. The Thogoto virus ML protein has recently been shown to
interact with the RNA polymerase II transcription factor IIB (TFIIB; Vogt
et al., 2008).However, theMLprotein–TFIIB interactionhad surprisingly
little effects onhost cell gene expression in general, but showed a strong
negative impact on the IRF3-regulated and NF-κB-regulated promoters(Vogt et al., 2008). Thus, it is conceivable that PRRSV Nsp1-mediated
CBP degradationmay also be negligible for general cellular transcription
but have a more speciﬁc and potent role for IRF3-regulated IFN
induction. The PRRSV Nsp1 protein and the Thogoto virus ML protein
may constitute a new class of viral antagonists for IFN regulation acting
to target CBP degradation.
In virus-infected cells, following the self-cleavage of Nsp1α and
Nsp1β from PP1, Nsp1 remains proteolytically inactive and no trans-
activity has been reported, and this is consistent with our ﬁndings. CBP
degradation was halted in the presence of MG132, a potent inhibitor of
the proteasome, thereby suggesting proteasome involvement in CBP
degradation by Nsp1. As with PRRSV Nsp1, pestivirus Npro is a papain-
Fig. 7. Lack of direct binding of Nsp1 to CBP. HeLa cells were transfected with pCMV-
Flag-Nsp1 for 24 h and stimulated with poly(I:C) for 6 h. Cell lysates were prepared and
subjected to co-immunoprecipitation using anti-CBP antibody (1st and 2nd panels from
top) or anti-Nsp1 antiserum (3 rd, 4th, and 5th panels). The immune complexes were
then subjected to Western blot analyses using anti-Flag-antibody to detect Nsp1α (4th
panel), anti-Nsp1β MAb (5th panel), and anti-CBP antibody (3 rd panel). Expression of
Nsp1α, Nsp1β, CBP, and β-actin is shown by speciﬁc antibodies in 6th, 7th, 8th, and 9th
panels, respectively.
Fig. 8. Inhibition of Nsp1-mediated CBP degradation by MG132. HeLa cells were
transfected with pCMV-Flag-Nsp1 for 24 h and treated with 0, 1, and 5 μMofMG132 for
16 h. Cell lysates were prepared for Western blot analysis using anti-CBP antibody
(upper panel) or anti-Flag antibody for Nsp1 detection (middle panel). The bottom
panel shows β-actin as a loading control.
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through IRF3 degradation via the proteasome-dependent pathway
(Chen et al., 2007; Gil et al., 2006). Similarly, NSP1-mediated IRF3
degradation in rotavirus is also proteasome-dependent (Graff et al.,
2002). Proteins targeted by proteasomes are degraded through
polyubiquitination. CBP/p300 degradation requires Mdm2 (murine
double minute 2) acting as an E3 ubiquitin ligase in the presence of
activated Ras (Sanchez-Molina et al., 2006), and it is therefore possible
that Nsp1 may also bring CBP to an E3 ligase complex by which CBP is
polyubiquitinated for subsequent degradation. In eukaryotes, the
proteasomes reside in both nucleus and cytoplasm (Peters et al.,
1994). In order for PRRSV Nsp1 to degrade CBP in the nucleus, Nsp1
must localize in thenucleus although PRRSV replicates in the cytoplasm.
The Nsp1 protein of equine arteritis virus (EAV), anothermember of the
Arteriviridae family, has been reported to localize in the nucleus (Tijmset al., 2002), and our studies also indicate that PRRSVNsp1 is localized in
both the cytoplasm and nucleus in virus-infected cells aswell as in Nsp1
gene-transfected cells (Fig. 4B, panel G). Therefore, it seems that Nsp1
triggers E3 ubiquitination of CBP by yet-to-be-identiﬁed mechanisms,
and subsequently degrades it via the proteasome-dependent pathway.
ThePRRSVNsp1protein contains a zincﬁngermotif of CxC-(14)-CxxC in
the Nsp1α subunit. Pestivirus Npro also contains a zinc-binding TRASH
motif (Ettema et al., 2003) and thismotif has been shown to be required
for IRF3 degradation in the regulation of IFN (Szymanski et al., 2009). It
is of interest to examine whether the zinc ﬁnger motif in PRRSV Nsp1
also regulates CBP degradation and IFN response, and such studies are
currently in progress.
Materials and methods
Cells, viruses, and antibodies
MARC-145 cells (Kim et al., 1993), HeLa cells (NIH AIDS Research
and Reference Reagent Program, Germantown, MD), and Dulac
porcine kidney (PK) cells (provided by L. A. Babiuk, Vaccine and
Infectious Disease Organization, Saskatoon, Canada) were grown in
Dulbecco's modiﬁed Eagle's medium (DMEM; Mediatech Inc., Man-
assas, VA) supplemented with 10% heat-inactivated fetal bovine
serum (FBS; HyClone, Logan, UT) in a humidiﬁed incubator with 5%
CO2 at 37 °C. Porcine alveolar macrophages (PAMs) were maintained
in Roswell Park Memorial Institute medium 1640 (RPMI 1640;
Mediatech Inc.) with 10% FBS. The PA8 strain of the North American
genotype PRRSV (Wootton et al., 2000) was used throughout the
study. The full-length genomic sequence of PA8 shares 99.2% identity
with the prototype PRRSV VR2332 of the North American genotype
(Nelsen et al., 1999). For PRRSV infection,MARC-145 cells were grown
to approximately 70% conﬂuency and infected at a multiplicity of
infection (MOI) of 5–10. Vesicular stomatitis virus expressing green
ﬂuorescent protein (VSV-GFP; Dalton and Rose, 2001) was kindly
provided by Adolph Garcia-Sastre (Mt. Sinai School of Medicine, New
York, NY). Sendai virus (Cantell strain) was obtained from American
Type Culture Collection (ATCC VR-907; Manassas, VA) and used for
IFN induction in porcine alveolar macrophages. Anti-FLAG antibody
was purchased from Sigma (St. Louis, MO). Antibodies for human
IRF3, human CBP, human HSP (heat shock protein) 90 and human
PARP (poly[ADP-ribose] polymerase protein) were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Phosphorylation-speciﬁc
antibody for phosphorylated IRF3 (Ser396) was purchased from Cell
Signaling (Danvers, MA). Rabbit antibody speciﬁc for PRRSV Nsp1 and
mouse monoclonal antibody (123–128) speciﬁc for Nsp1β subunit
were kindly provided by Y. Fang (South Dakota State University,
Brookings, SD). HRP-conjugated anti-mouse and anti-rabbit
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Laboratories (West Grove, PA). Alexa Fluor 488- and 594-conjugated
secondary antibodies are purchased from Invitrogen (Carlsbad, CA).
Chemicals
Polyinosinic:polycytidylic acid (poly[I:C]), DAPI (4′, 6-diamidino-
2-phenylindole) and cycloheximide (CHX) were purchased from
Sigma. MG-132 was purchased from Calbiochem (Gibbstown, NJ).
Plasmids and DNA cloning
The Nsp1 coding sequence was cloned by RT-PCR from the genomic
RNA of PRRSV strain VR2332 using forward (5′-AAGATCTCCCATGTCT-
GGGATACTTGATCGGTGC-3) and reverse primers (5′-AAAGCTTGCCAC-
TTGTGACTGCCAAAC-3′). The Nsp1 sequence of PA8 and VR2332 strains
was 99.9% identical (Wootton et al., 2000). The Nsp1 gene was cloned
into the pGEM-T easy vector (Promega; Madison,WI) and subcloned at
the Bgl II and Hind III sites of pCMV-Tag1 plasmid (Stratagene; La Jolla,
CA) so that Nsp1 could be expressed as a fusion protein with the
upstream FLAG tag. This construct was designated as pCMV-Flag-Nsp1.
DNA constructs of 4xIRF3-Luc, IFN-β-Luc and TATA-Luc, which were
used for luciferase assay, were kindly provided by Stephan Ludwig
(Ehrhardt et al., 2004; Institute of Molecular Medicine, Heinrich Heine
Universtät, Düsseldorf, Germany). The 4xIRF3-Luc construct contains
four copies of the IRF3 responsive PRDI/III motif of the IFN-β promoter
in front of the luciferase reporter gene.
Transfection and protein expression
Transfection was performed using Lipofectamine 2000 (Invitro-
gen; Carlsbad, CA) according to manufacturer's instructions. HeLa
cells were plated in 6-well plates and grown to 80% conﬂuency. The
transfection mix containing 2 μg of DNA and 1.5 μl of Lipofectamine
2000 in Opti-MEM I (Invitrogen; Carlsbad, CA) was incubated at room
temperature (R/T) for 20 min and added to each well. After 4 h, the
transfection mix was replaced with fresh medium. In some experi-
ments, CHX and MG132 were added for 2, 4, 6 or 8 h prior to harvest.
Cells were collected 24 h post-transfection.
Quantitative RT-PCR
MARC-145 cells grown in 12-well plates were infected with PRRSV
for 24 h at MOI of 5–10 and transfected with 1 μg poly(I:C). At 15 h of
poly(I:C) stimulation, total cellular RNA was extracted for real-time RT-
PCR using TRIzol (Invitrogen; Carlsbad, CA) according to manufacturer's
instructions. Quantitative PCR reactions were performed in the Light-
Cycler system using SYBR Green I (Roche;Mississauga, Ontario). In 20 μl
capillaries, the reaction consisted of forward and reverse primers and 5×
master mix (PCR buffer, 1 mMMgCl2, 10 mM dNTPs, hot start Taq DNA
polymerase, SYBR Green I; LS DNAMaster SYBR Green I Kit). The primer
sequences for human IFN-α and GAPDH (glyceraldehyde 3-phosphate
dehydrogenase) were as follows: IFN-α forward, 5′-GCAGCATCTGCAA-
CATCTAC-3′; IFN-α reverse, 5′-GGATCATCTCATGGAGGACAG-3′;
GAPDH forward, 5′-CGGAGTCAACGGATTTGGTCGTA-3′; GAPDH reverse,
5′-AGCCTTCTCCATGGTGGTGAAGAC-3′. The mRNA levels of indicated
genes were normalized to that of GAPDHmRNA. RelQuant (Roche) was
used to calculate the relative fold change of IFN-α mRNA between
differently treated samples of MARC-145 cells. Two independent
experimentswere conducted in duplicate and the average of normalized
values obtained from each infection and transfection are presented.
Luciferase reporter assay
HeLa cells were grown in a 12-well plate at a density of 5 × 104
cells/well and were transfected with pCMV-Flag-Nsp1 and 4xIRF3-Luc or IFN-β-Luc along with the internal control Renilla construct (TK-
RL) in a ratio of 1:1:0.1 in a total of 1 μg using Lipofectamine 2000
(Invitrogen) according to manufacturer's instructions. At 24 h post-
transfection, cells were transfected again with 0.5 μg of poly(I:C) for
16 h and cell lysates were prepared for luciferase assays. Luciferase
activities were measured using the Dual-Glo Luciferase Assay System
(Promega) according to the manufacturer's instructions. The results
are presented as the fold induction, which was the relative luciferase
activity of the poly(I:C) treated cells divided by that of control. Assays
were conducted in triplicates and the data representing relative ﬁreﬂy
luciferase activity were normalized using Renilla (sea pansy)
luciferase activity.
Immunoprecipitation, co-immunoprecipitation, and Western blot
analysis
Gene-transfectedHeLa cells were lysed in lysis buffer (20 mMTris/
HCl [pH 7.4], 150 mMNaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100,
1 mM Na3VO4,) containing 1 mg/ml aprotinin, 1 mg/ml leupeptin,
and 1 mM PMSF (phenylmethanesulphonyl ﬂuoride). Insoluble
materials were removed by centrifugation at 4 °C for 10 min at
13,400 ×g in a microcentrifuge (Eppendorf 5415R), and cell lysates
were incubated with a primary antibody for 1 h at 4 °C. Antigen–
antibody complex was collected using protein A-Sepharose beads
(Amersham; Piscataway, NJ). The protein A–antibody complex was
washed three times at 4 °C with the lysis buffer followed by SDS-7.5%
or -12% PAGE under denaturing conditions. Total cell extracts were
preparedby lysing cells in the Laemmli's sample buffer and resolved by
SDS-PAGE. The gel was transferred to Immobilon-P membrane
(Millipore). Blocking and subsequent incubation with primary and
secondary antibodies were performed in 5% skim milk powder
dissolved in TBS-T (10 mM Tris–HCl [pH 8.0], 150 mM NaCl, 1%
Tween 20). Blots were incubated with primary antibody for 1 h at R/T
followed by horseradish peroxidase-conjugated secondary antibody
for 1 h. Themembraneswerewashed and exposed to x-ray ﬁlms using
an enhanced chemiluminescence reaction (Pierce; Rockford, IL).
Immunoﬂuorescence
Cells were grown on cover slips to 40% conﬂuency and then
infected with virus for 24 h or transfected with the PRRSV Nsp1
construct pCMV-Flag-Nsp1 for 24 h. Virus-infected and gene-trans-
fected cells were treated by transfection with 1 μg of poly(I:C) for 6 h.
Cells were washed once with PBS and ﬁxed with 4% paraformalde-
hyde for 30 min. Cells were then permeabilized with 0.3% Triton X-
100 and blocked for 1 h in PBS containing 3% BSA. Cells were
incubated with anti-IRF3, anti-Flag, or anti-N antibody for 1 h at R/T
followed by incubation with Alexa Fluor 488- and 594-conjugated
secondary antibodies for 1 h. Nuclear staining was performed with
DAPI (4′,6-diamidino-2-phenylindol) for 5 min at R/T. Cells were
examined under ﬂuorescent microscope (Nikon Eclipse TS100).
Cell fractionation
HeLa cells were grown in 6-well plates to 80% conﬂuency and were
transfectedwith 2 μgof pCMV-Flag-Nsp1 for 24 h.Cellswere inducedby
transfectionwith 1 μg poly(I:C) for 6 h and fractionated using a nuclear/
cytosol fractionation kit (BioVision; Mountain View, CA) according to
the manufacturer's instructions with minor modiﬁcations. Brieﬂy, cells
were collected in PBS and centrifuged at 4 °C for 5 min at 5000 ×g in a
microcentrifuge (Eppendorf 5415R). Cell pellets were resuspended in
CEB (cytosolic extraction buffer)-A, and incubated for 10 min on ice
prior to addition of CEB-B. The lysateswere centrifuged at 4 °C for 5 min
at 12,000 rpm in themicrocentrifuge and the supernatantswere kept as
a cytoplasmic fraction. The nuclear pellet was resuspended in NEB
(nuclear extraction buffer) and vortexed for 30 s. This stepwas repeated
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for 10 min at 12,000 rpm and the supernatants were kept as a
nuclear fraction. The cytoplasmic and nuclear fractions were resolved
by SDS-PAGE followed by Western blot.
Interferon bioassay
For IFN bioassays, HeLa cells were used to determine the effects
of Nsp1 upon gene transfection. To determine the effects of PRRSV
infection, porcine alveolar macrophages (PAMs) were used. To deter-
mine the potency of IFN, supernatants collected from HeLa cells
were analyzed in MARC-145 cells, and supernatants obtained from
PAMswere analyzed in Dulac porcine kidney (PK) cells using vesicular
stomatitis virus expressing green ﬂuorescence protein (VSV-GFP)
(12). HeLa cells grown in 6-well plates were transfected with 2 μg of
pCMV-Flag-Nsp1 using Lipofectamine 2000 and incubated for 24 h.
Nsp1-expressing cells were then stimulated with 1 μg of poly(I:C) for
6 h by transfection using Lipofectamine. Supernatants were collected
and 2-fold dilutions were made in DMEM for VSV-GFP bioassays. For
PRRSV and Sendai virus, PAMs were infected with either virus at an
MOI of 5 and incubated for 48 h. Culture supernatants were collected
and virus infectivity in the supernatants were ultraviolet (UV)-irra-
diated for 30 min under a 75wUV lampat 33 cmdistance. The samples
were then 2-fold diluted in DMEM for IFN bioassays. MARC-145 or
Dulac PK cells were grown in 96-well plates and, at 70% conﬂuency,
incubated with each dilution of supernatants. At 24 h incubation,
the cells were infected with VSV-GFP at an MOI of 0.1 and further
incubated for 16 h. Cells were ﬁxed with 4% paraformaldehyde, and
expression of green ﬂuorescence protein was examined under an
inverted ﬂuorescence microscope (Nikon Eclipse TS100).
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